Sentinel lymph node biopsy in early breast cancer: The experience of the european institute of oncology in special clinical scenarios

Breast Care

Volumn 6, Issue 3, 2011, Pages 208-214

  Toesca, Antonio ^a   Luini, Alberto ^a   Veronesi, Paolo ^a   Intra, Mattia ^a   Gentilini, Oreste ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Axillary dissection; Axillary staging; Breast cancer; Sentinel node

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DECISION MAKING; EARLY CANCER; EXPERIENCE; FEMALE; GENDER; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; VALIDATION PROCESS;

EID: 79959883690     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000329192     Document Type: Article

References (34)

1. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F, Gatti G, Mazzarol G, De Cicco C, Vezzoli D: Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010;251:595-600.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8; discussion 398-401.
3. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;339:941-6. (Pubitemid 28455095)
4. De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, Galimberti V, Calza P, Viale G, Veronesi U, Paganelli G: Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080-4. (Pubitemid 29001793)
5. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zucali P, Veronesi U: Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998;42:49-53. (Pubitemid 28244267)
6. Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito Lima L, Tullii M, Zurrida S: Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3,548 cases. Eur J Cancer 2009;45:1381-8.
7. Viale G, Bosari S, Mazzarol G, Galimberti V, Luini A, Veronesi P, Paganelli G, Bedoni M, Orvieto E: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-8. (Pubitemid 29244852)
8. Luini A, Caldarella P, Gatti G, Veronesi P, Vento AR, Naninato P, Arnone P, Sangalli C, Brenelli F, Sosnovskikh I, Peradze N, Dussan Luberth CA, Viale G, Paganelli G: The sentinel node biopsy under local anesthesia in breast cancer: advantages and problems, how the technique influenced the activity of a breast surgery department; update from the European Institute of Oncology with more than 1,000 cases. Breast 2007;16:527-32. (Pubitemid 47491611)
9. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-26. (Pubitemid 40432319)
10. Intra, Mattia MD; Rotmensz, Nicole MSc; Veronesi, Paolo MD; Colleoni, Marco MD; Iodice, Simona MSc; Paganelli, Giovanni MD; Viale, Giuseppe MD, FRCPath, Veronesi, Umberto MD: Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European Institute of Oncology on 854 patients in 10 years. Ann Surg 2008;247:315-9.
11. Jackman RJ, Burbank F, Parker SH, Evans WP 3rd, Lechner MC, Richardson TR, Smid AA, Borofsky HB, Lee CH, Goldstein HM, Schilling KJ, Wray AB, Brem RF, Helbich TH, Lehrer DE, Adler SJ: Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502. (Pubitemid 32121065)
12. Cox CE, Cox JM, Ramos D, Meade TL: Intra-mammary sentinel lymph nodes: what is the clinical significance? Ann Surg Oncol 2008;15:1273-4.
13. Galimberti V, Veronesi P, et al.: Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 2002;9:924-8. (Pubitemid 35265646)
14. Intra M, Garcia-Etienne CA, Renne G, Trifirò G, Rotmensz N, Gentilini OD, Galimberti V, Sagona A, Mattar D, Sangalli C, Gatti G, Luini A, Veronesi U: When sentinel lymph node is intramammary. Ann Surg Oncol 2008;15:1304-8.
15. Shrenk P, Wayand W: Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001;357:122. (Pubitemid 32094920)
16. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegal B, et al.: Retrospective analysis of sentinel node localization in multifocal, multi-centric, palpable, or non palpable breast cancer. J Nucl Med 2003;44:7-10. (Pubitemid 36077705)
17. Gentilini O, Trifirò G, Soteldo J, Luini A, Intra M, Galimberti V, Veronesi P, Silva L, Gandini S, Paganelli G, Veronesi U: Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol 2006;32:507-10. (Pubitemid 44226007)
18. Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G, Maisonneuve P, Veronesi U: Predicting the status of axillary sentinel lymph nodes in 4,351 patients with invasive breast carcinoma treated in a single institution. Cancer 2005;103:492-500.
19. Intra M, Veronesi P, Gentilini OD, Trifirò G, Berrettini A, Cecilio R, Colleoni M, Rietjens M, Luini A, Paganelli G, Veronesi U: Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol 2007;95:175-89.
20. Rodriguez Fernandez J, Martella S, Trifirò G, Caliskan M, Chifu C, Brenelli F, Botteri E, Rossetto F, Rotmensz N, Rietjens M, Veronesi P: Sentinel node biopsy in patients with previous breast aesthetic surgery. Ann Surg Oncol 2009;16:989-92.
21. Intra M, Trifirò G, Galimberti V, Gentilini O, Rotmensz N, Veronesi P: Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 2007;94:1216-9. (Pubitemid 47584769)
22. Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M, et al.: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51. (Pubitemid 39295022)
23. Gentilini O, Cremonesi M, Toesca A, Colombo N, Peccatori F, Sironi R, Sangalli C, Rotmensz N, Pedroli G, Viale G, Veronesi P, Galimberti V, Goldhirsch A, Veronesi U, Paganelli G: Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 2010;37:78-83.
24. Breslin TM, Cohen L, Sahin A, et al.: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-6.
25. Schwartz GF, Meltzer AJ: Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374-9. (Pubitemid 37158910)
26. Mamounas EP, Brown A, Anderson S, et al.: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2005;23:2694-702. (Pubitemid 46179459)
27. Xing YMF, Cox DD, Kuerer HM, et al.: Meta-analysis of sentinel lymph node biopsy after pre-operative chemotherapy in patients with breast cancer. Br J Surg 2006;93:539-46.
28. Veronesi P, Gentilini O, Fernandez JR, Magnoni F: Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy. Breast 2009;18(suppl 3):S90-2.
29. Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C, Gatti G, Silva L, Renne G, Cassano E, Veronesi U: Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist 2007;12:512-5. (Pubitemid 350012112)
30. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53. (Pubitemid 36951366)
31. Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS; International Breast Cancer Study Group: Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006;24:337-44. (Pubitemid 46630451)
32. Veronesi U, Orecchia R, Zurrida S, Galimberti V, Luini A, Veronesi P, Gatti G, D'Aiuto G, Cataliotti L, Paolucci R, Piccolo P, Massaioli N, Sismondi P, Rulli A, Lo Sardo F, Recalcati A, Terribile D, Acerbi A, Rotmensz N, Maisonneuve P: Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005;16:383-8. (Pubitemid 40458313)
33. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Demonty G, Duez N, Cataliotti L, Klinkenbijl J, Westenberg HA, van der Mijle H, Hurkmans C, Rutgers EJ: Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 2010;28:731-7.
34. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M: Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75.